David Lutton, MD
Orthopaedic Surgery · Washington, DCNPI 1770747230
Payments from drug & device makers
Across 660 payments — averaging $580.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$328K
- Avanos Medical$22K
- Restor3d, Inc.$19K
- Supreme Orthopedic Systems, LLC$5K
- Stryker$5K
- Novartis$2K
- plus $2K from 18 others
Across 1 payment — averaging $450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$450
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 473 | $327,768 |
| Avanos Medical | 14 | $21,667 |
| Restor3d, Inc. | 18 | $18,615 |
| Supreme Orthopedic Systems, LLC | 51 | $5,408 |
| Stryker | 51 | $5,127 |
| Novartis | 1 | $1,938 |
| Pinnacle, Inc | 2 | $928 |
| Ferring Pharmaceuticals Inc. | 14 | $300 |
| Zimmer Biomet | 4 | $253 |
| Fidia Pharma USA Inc. | 7 | $159 |
| Smith+Nephew | 5 | $151 |
| KCI USA, Inc. | 1 | $125 |
| Amgen | 5 | $93 |
| Exactech, Inc. | 1 | $81 |
| Encore Medical, LP | 1 | $72 |
| Pacira Pharmaceuticals Incorporated | 2 | $45 |
| Johnson & Johnson | 2 | $43 |
| Stability Biologics, LLC | 1 | $29 |
| Trevena, Inc. | 2 | $27 |
| Bioventus LLC | 1 | $21 |
| ERMI LLC | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Medartis Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $15 |
How this compares
$382,921 in reported general payments places this provider in the 90th percentile of 46 orthopaedic surgery providers in District of Columbia.
See all orthopaedic surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Washington
- Akhil KhannaWashington$2.1M
- Seyed KalantarWashington$907K
- Robert HenshawWashington$848K
- Scott FaucettWashington$799K
- Savyasachi ThakkarWashington$246K
- Joseph FergusonWashington$84K
- Robert SterlingWashington$38K
- Ryan MurrayWashington$32K
- Sandesh RaoWashington$21K
- James DebritzWashington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.